FI20000780A - Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi - Google Patents

Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi Download PDF

Info

Publication number
FI20000780A
FI20000780A FI20000780A FI20000780A FI20000780A FI 20000780 A FI20000780 A FI 20000780A FI 20000780 A FI20000780 A FI 20000780A FI 20000780 A FI20000780 A FI 20000780A FI 20000780 A FI20000780 A FI 20000780A
Authority
FI
Finland
Prior art keywords
drug
dosage form
controlled release
oral dosage
oral
Prior art date
Application number
FI20000780A
Other languages
English (en)
Swedish (sv)
Other versions
FI20000780A0 (fi
Inventor
Mia Saekkinen
Martti Marvola
Original Assignee
Novasso Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novasso Oy filed Critical Novasso Oy
Priority to FI20000780A priority Critical patent/FI20000780A/fi
Publication of FI20000780A0 publication Critical patent/FI20000780A0/fi
Priority to AU2001252296A priority patent/AU2001252296A1/en
Priority to PCT/FI2001/000322 priority patent/WO2001076562A1/en
Publication of FI20000780A publication Critical patent/FI20000780A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
FI20000780A 2000-04-03 2000-04-03 Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi FI20000780A (fi)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI20000780A FI20000780A (fi) 2000-04-03 2000-04-03 Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
AU2001252296A AU2001252296A1 (en) 2000-04-03 2001-04-03 A peroral pharmaceutical formulation for controlled release of a drug
PCT/FI2001/000322 WO2001076562A1 (en) 2000-04-03 2001-04-03 A peroral pharmaceutical formulation for controlled release of a drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20000780A FI20000780A (fi) 2000-04-03 2000-04-03 Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi

Publications (2)

Publication Number Publication Date
FI20000780A0 FI20000780A0 (fi) 2000-04-03
FI20000780A true FI20000780A (fi) 2001-10-04

Family

ID=8558105

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20000780A FI20000780A (fi) 2000-04-03 2000-04-03 Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi

Country Status (3)

Country Link
AU (1) AU2001252296A1 (fi)
FI (1) FI20000780A (fi)
WO (1) WO2001076562A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005065685A1 (en) * 2004-01-06 2005-07-21 Panacea Biotec Ltd. Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer
FI116625B (fi) 2004-01-28 2006-01-13 Macrocrystal Oy Menetelmä proteiinien kiteyttämiseksi hiilihydraattirunkoisilla polymeereillä
GB0607534D0 (en) 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
JP2011511782A (ja) 2008-02-12 2011-04-14 アボット・ラボラトリーズ 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
PT2659881T (pt) 2012-04-30 2018-01-29 Tillotts Pharma Ag Formulação de fármaco de libertação retardada
KR102174942B1 (ko) 2013-10-29 2020-11-06 틸로츠 파마 아게 지연 방출 약물 제형
EP3409688A1 (en) 2017-05-31 2018-12-05 Tillotts Pharma Ag Topical treatment of inflammatory bowel disease using anti-tnf-alpha antibodies and fragments thereof
ES2938609T3 (es) 2017-09-20 2023-04-13 Tillotts Pharma Ag Preparación de formas farmacéuticas sólidas que comprenden anticuerpos mediante estratificación de solución/suspensión
EP3459527B1 (en) 2017-09-20 2022-11-23 Tillotts Pharma Ag Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and spheronization
EP3459529A1 (en) 2017-09-20 2019-03-27 Tillotts Pharma Ag Preparation of sustained release solid dosage forms comprising antibodies by spray drying
EP3662902A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
WO2020114616A1 (en) 2018-12-07 2020-06-11 Tillotts Pharma Ag Topical treatment of immune checkpoint inhibitor induced diarrhoea, colitis or enterocolitis using antibodies and fragments thereof
EP3662900A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
EP3662898A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Solid composition comprising mesalazine
EP3662901A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Delayed release drug formulation comprising an outerlayer with an enzymaticyaaly degradable polymer, its composition and its method of manufacturing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0813748B2 (ja) * 1990-04-23 1996-02-14 帝國製薬株式会社 大腸崩壊性ポリペプチド系経口製剤
US5830883A (en) * 1995-11-06 1998-11-03 Duquesne University Of The Holy Ghost Methods of creating a unique chitosan and employing the same to form complexes with drugs, delivery of the same within a patient and a related dosage form
DE69916288T2 (de) * 1998-08-14 2005-03-24 F. Hoffmann-La Roche Ag Lipasehemmer und chitosan enthaltende arzneimittel

Also Published As

Publication number Publication date
FI20000780A0 (fi) 2000-04-03
AU2001252296A1 (en) 2001-10-23
WO2001076562A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
CY2007031I2 (el) Συνθεση στοματικης δοσολογιας παρατεταμενης απελευθερωσης
NO20003219L (no) Oral farmasøytisk doseringsform med pulsert frigivningsvirkning
DE60115418D1 (de) Mikroinfusionsvorrichtung zur verabreichung von medikamenten
PL356358A1 (en) Solid dosage form of someticone for oral administration
FR2795324B1 (fr) Compositions pharmaceutiques stabilisees
NO20030713D0 (no) Oral faststoffdose vaksine
HUP0401714A3 (en) Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
DE69936002D1 (de) Angepasster löffel zur oralen medikamenten-verabreichung
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
FI4823U1 (fi) Muunnetulla tavalla vapauttava lääkeformulaatio
EE05020B1 (et) Glburiidi ravimkoostis
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
HK1072194A1 (en) Oral dosage form for controlled drug release
NO20043007L (no) Farmasoytisk suspensjon for oral administrering
HUP0401599A3 (en) Extended release oral dosage form
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
EP1357898A4 (en) ORAL DOSAGE FORM WITH ENHANCED REGULATED RELEASE
PT1385512E (pt) Utilizacao de derivados de piridoindolona para preparacao de medicamentos anticancerigenos
SE0004677D0 (sv) Intraaxonal läkemedelsadministration
PL341178A1 (en) Oral pharmaceutical dosage forms